Avelas Biosciences' Series C Round

Avelas Biosciences raised a round of funding on August 18, 2016.

Avelas Biosciences is a biotechnology company focused on developing fluorescent technologies that advance a new standard-of-care for cancer surgery. Avelas aims to create better outcomes for cancer pa…

Articles about Avelas Biosciences' Series C Round: